Truncation of the envelope cytoplasmic tail has enabled FIV, SIV, and some laboratory HIV-1 strains to acquire broader cellular tropism and enhanced fusogenicity. Here we have characterized a primary CD4-independent HIV-1 isolate (92UG046-T8) with a truncated cytoplasmic tail that was able to infect and induce syncytia in primary lymphocytes from human, chimpanzee, and monkey, as well as CD4-negative cell lines from human and monkey. Increased syncytia were also noticeable with 293 cells expressing the cloned envelope from the 92UG046-T8 isolate suggesting envelope-mediated cellular fusion. Except pooled serum from HIV-1-infected individuals, monoclonal antienvelope antibodies or antibodies/antagonists against CD4, CXCR4, and CCR5 were not able to prevent infection by the 92UG046-T8 isolate. This is the first report showing a primary HIV-1 variant with truncated cytoplasmic tail which is highly fusogenic and can infect a broad range of cells from human and non-human origins. In vivo evolution of similar HIV-1 mutants may have important implications in AIDS pathogenesis. D
Introduction
The envelope glycoprotein of the human immunodeficiency virus (HIV) plays a pivotal role for infection and target cell selection. HIV envelope is synthesized as a precursor protein (gp160), which is processed into surface gp120 (SU) and transmembrane gp41 (TM) subunits by cellular protease. Although the SU domain contains the primary receptor/co-receptor binding regions, the TM protein of the viral envelope also plays an important role in the eventual virus-cell fusion and determination of the target cells (Freed, 2001; Willey et al., 1988; Yang and Compans, 1996) . It has been previously shown that changes in the functional domains of the TM protein can dramatically alter virus infectivity, fusogenicity as well as cytopathicity of primate lentiviruses (Bergeron et al., 1992; Chen, 1994; Dubay et al., 1992a; Freed and Myers, 1992; Freed et al., 1990 Helseth et al., 1990; Owens et al., 1994) .
One unusual feature of most lentiviruses is the long cytoplasmic tail of the TM protein. While most retroviruses have a cytoplasmic domain that is generally less than 35 aa long, the cytoplasmic tail of the SIV and HIV isolates are usually composed of over 150 amino acids (Earl et al., 1991; Kowalski et al., 1987) . The specific purpose of a long cytoplasmic tail for these viruses remains unclear. A premature stop codon in the envelope TM protein of several SIV (Chakrabarti et al., 1987; Hirsch et al., 1987) and HIV-2 isolates (Hahn et al., 1987; Zagury et al., 1988) has resulted in mutants with short cytoplasmic tail. The SIV mutants with truncated cytoplasmic tail exhibited enhanced fuso- genic ability and were able to infect a wider range of target cells, including cells of human origin, compared to the wildtype viruses (Chakrabarti et al., 1989; Hirsch et al., 1989; Johnston et al., 1993; Kodama et al., 1989; Ritter et al., 1993; Zingler and Littman, 1993) . Truncation of the envelope cytoplasmic tail of the human T cell leukemia virus type 1 (HTLV-1) has also enabled fusion with otherwise resistant cell lines from other species suggesting a link between short tail and widening of the target cell types (Kim et al., 2003) . Feline immunodeficiency virus (FIV) (Lerner and Elder, 2000) , equine anemia virus (EAV) (Rice et al., 1990) , and maedi-visna virus (MVV) (Zeilfelder and Bosch, 2001 ) mutants have also shown enhanced fusogenicity and infectivity after deletion of their envelope cytoplasmic tails. In fact, the enhanced viral fusogenicity and/or infectivity associated with the truncation of the cytoplasmic tail are not limited to the lentivirus family alone. The removal of the C-terminal 16 amino acids from the cytoplasmic tail, the R peptide, resulted in a more fusogenic murine leukemia virus (MuLV) (Aguilar et al., 2003; Green et al., 1981) and similar changes in the TM domain have been associated with increased fusion with the Mason -Pfizer monkey virus (M-PMV) (Brody et al., 1992) and the gibbon ape leukemia virus (GaLV) (Christodoulopoulos and Cannon, 2001) .
The biological effects of truncation of the envelope cytoplasmic tail of HIV-1 have been studied with some laboratory mutants (Edwards et al., 2001; Gabuzda et al., 1992; Hoffman et al., 1999; LaBranche et al., 1999; Mulligan et al., 1992; Murakami and Freed, 2000; Piller et al., 2000; Wilk et al., 1992) . Although most studies have reported reduced infectivity of the HIV-1 variants with truncated cytoplasmic tail, these mutants almost always showed enhanced fusogenic capacity in spite of low viral titers (Dubay et al., 1992b; Gabuzda et al., 1992; LaBranche et al., 1999) . KB-2 was the first reported HIV-1 strain with a truncated cytoplasmic tail that originally came from a Japanese patient who had AIDS. However, this mutant was isolated from a chronically infected T cell line by serial passage for extended period of time (Shimizu et al., 1990) . More recently, another HIV-1 mutant with a short TM domain was isolated by long-term passage of an early HIV-1 reference strain (RF) in transformed H9 cells. Interestingly, this short-tail HIV-1 mutant also exhibited extreme fusogenic properties in vitro (Jones et al., 2002) . It was assumed that these short-tail HIV-1 mutants might have emerged under selection pressure during in vitro propagation of the primary isolates on tumor cell lines. Thus, it remains unclear whether cytoplasmic tail-deleted HIV-1 viruses may evolve in vivo. The potential biological effects of the cytoplasmic tail deleted HIV-1 strains also remains unknown at the present time. In vivo evolution of an increasingly fusogenic strain with a broad cellular tropism may have important implications in HIV-1 disease pathogenesis. We have recently reported isolation of CD4-independent HIV-1 variants from several patients. One of these isolates was found to have a truncated envelope cytoplasmic tail (Zerhouni et al., 2004b) . In this study, we have examined the broad tropism of this unique CD4-independent HIV-1 isolate with a deleted TM domain and compared it with the parental isolate that had a full-length envelope and that generally maintained a normal CD4/X4-tropic phenotype.
Results

HIV-1 isolate with a truncated envelope cytoplasmic tail
We have recently described the isolation of CD4-independent HIV-1 variants from the bulk viral quasispecies of a number of patients. One of these CD4-independent isolates, 92UG046-T8, was found to have a sharply truncated envelope cytoplasmic tail due to a premature stop-codon in the TM domain (Zerhouni et al., 2004b) . It became clear from the very early stage of isolation of the 92UG046-T8 strain that this isolate was extremely fusogenic for both CD4+ and CD4-negative cells. In contrast, the parental 92UG046 isolate was fusogenic only for CD4+ cells and PBL, but not for CD4-depleted PBL (data not shown). It was unlikely that the CD4-independent and fusogenic 92UG046-T8 isolate emerged in vitro during the isolation process for several reasons. First, the 92UG046-T8 strain was isolated from the parental 92UG046-infected primary CD8+ lymphocytes in short-term (2 -3 weeks) cocultures. Next, unlike the previously described HIV-1 mutants with truncated cytoplasmic tail that emerged from transformed cell lines (Jones et al., 2002; Shimizu et al., 1990) , the 92UG046-T8 isolate was never cultivated with any tumor cell lines that could produce a selective pressure for mutation. To further affirm that the truncated envelope sequence of the 92UG046-T8 isolate was indeed preexisting in the parental 92UG046 isolate, we designed a novel heteroduplex tracking assay (HTA) to detect the stop codon within the gp41 sequence of the 92UG046-T8 isolate.
Comparison of the original 92UG046 isolate and the env clones derived from the CD4-independent 92UG046-T8 as well as the dominant 92UG046 isolates by HTA showed that the 92UG046-T8 sequence with the stop codon in the envelope cytoplasmic tail was present in the parental 92UG046 isolate at approximately 10% of the RNA pool suggesting that the 92UG046-T8 isolate with a truncated envelope was present as a minority variant in the viral quasispecies of this patient (Fig. 1) .
Another striking feature that was noticeable early during the isolation of the 92UG046-T8 strain from the infected CD8+ cell co-cultures was the conspicuous absence of significant level of viral p24 antigens in the culture supernatants in spite of an abundance of prominent syncytia in these co-cultures. The 92UG046-T8-infected culture supernatants also showed little RT activity and contained low levels of viral RNA although these cultures remained consistently HIV positive by PCR (data not shown).
Interestingly, in spite of minimal p24 or RT production, the 92UG046-T8-infected culture supernatants showed the presence of high levels of infectious viral particles (TCID 50 ) as measured by de novo infection and syncytium induction in MT-2 cells (Table 1) . We have previously shown that the 92UG046-T8, but not its parental 92UG046, isolate also produced syncytia in CD8+ cells (Zerhouni et al., 2004b) . In contrast, the original 92UG046 isolate produced syncytia and high levels of p24 antigens in CD4+ cells and PBLs but not in purified CD8+ cells (Table 1) . Together, these results suggest that the 92UG046-T8 isolate with a short envelope cytoplasmic tail that was present as a minority variant in the quasispecies (92UG046) was highly fusogenic for both CD4+ and CD8+ cells. Similar results have been reported with other HIV-1 mutants with truncated envelope cytoplasmic tail that produced increased number of syncytia in spite of reduced virus production (Gabuzda et al., 1992; Piller et al., 2000) .
Infection of CD4+ and CD8+ lymphocytes
We have previously shown that the 92UG046-T8 isolate was able to induce syncytia in both CD4+ and CD8+ cells (Zerhouni et al., 2004b) . Although low levels of HIV-1 replication could be detected with primary CD8+ cell population, such infections are believed to occur through co-expression of CD4 molecules in a small percentage of the CD8+ cells (Flamand et al., 1998; Kitchen et al., 2004) . To further analyze the infection and syncytium induction in CD8+ lymphocytes by the 92UG046-T8 isolate, purified CD8+ and CD4+ cells (or PBLs) from the same donor (a new donor for each of four separate experiments in order to avoid any donor-specific genetic bias) were infected simultaneously with the 92UG046-T8 or its parental 92UG046 isolate. Infection of both CD4+ cells/PBLs and CD8+ cells by the 92UG046-T8 isolate resulted in rapid (1-2 days) induction of syncytia (data not shown) and high levels of virus production ( Fig. 2A ). Significant cytopathic effects were also observed after infection of both PBLs and CD8+ cells by the 92UG046-T8 isolate (Fig. 2B) . Overall, there was no measurable difference between the infections of CD4+ (or PBLs) or CD8+ cells in the appearance or number of syncytia, the level of infectious virus produced, or the cytopathic effects with the 92UG046-T8 isolate. In contrast, the parental 92UG046 isolate basically infected only the PBLs (Fig. 1A ) and CD4+ cells (data not shown). Infection Infectivity of various cells were determined by p24 ELISA (p24) (positive limit above 200 pg/ml); RT assay (RT) (positive limit above 1000 cpm/ml with appropriate controls); IU, infectious unit (positive limit determined by increasing TCID 50 titers in MT-2 cells); formation of syncytia (SI) (positive limit detected by microscopic examination); and co-cultures (CoC) (positive limit detected by evidence of infection with other indicator cells). by the 92UG046 isolate also resulted syncytia only in the CD4+ cell population; these syncytia were less abundant and were produced at a slower rate (3 -5 days) (data not shown). Unlike the 92UG046-T8 isolate, infection of CD8+ cells by the parental 92UG046 isolate led to little or no virus production ( Fig. 2A ) and little cytopathic effects (Fig. 2B ). Sharp increase in the production of infectious viral titers ( Fig. 2A ) with concomitant killings of the infected cells ( Fig.  2B ) indicated efficient infection of both the CD4+ and CD8+ lymphocytes by the 92UG046-T8 isolate. We also analyzed the expression of CD4 and CD8 molecules on PBLs (Fig. 2C ) or CD8+ cells (data not shown) after infection with the 92UG046-T8 or its parental 92UG046 isolate. As infection with the parental 92UG046 isolate progressed, the CD4+ cell population present in the PBLs was selectively depleted and by 11 days post infection, 95% of the cells present in the PBL population were single CD8+ indicating the true CD4-tropic nature of this isolate. In marked contrast, no specific killings of the CD4+ cells were observed after infection of the same PBL population by the 92UG046-T8 isolate even after 11 days when viral replication had already peaked. It was obvious that the marked cytopathic effects that were seen in the 92UG046-T8-infected PBL cultures caused a proportionate loss of both the CD4+ and CD8+ cell types since even when most of the cells present in the 92UG046-T8-infected PBL cultures were dead by 11 days after infection (Fig. 2B ), the phenotypes of the remaining viable cells present in these cultures remained almost identical to the uninfected control cells (Fig. 2C ). There was a relative increase in the CD8+ cells and proportionate loss of CD4+ cells in the uninfected PBL cultures probably as a result of enhanced PHA stimulation of the CD8+ cells. Nevertheless, loss of both the CD4+ and CD8+ cells in the 92UG046-T8-infected PBL cultures indicated a dual (CD4/CD8)-tropism for this isolate. Apart from slight up-regulation in CD8 expression, there were no other changes in the surface expression of the 92UG046-T8-infected CD8+ lymphocytes (data not shown). Production of increasing viral titers ( Fig. 2A ) and rapid induction of death of the infected cells (Fig. 2B) established infection of the CD8+ lymphocytes by the 92UG046-T8 isolate. Taken together, these data demonstrate that unlike the parental 92UG046-T8 strain that primarily infected the CD4+ cells, the 92UG046-T8 isolate was infectious and cytopathic for both the CD4+ and CD8+ cells.
Antibody neutralization
CD4-independent HIV isolates are generally reported to be more sensitive to antibody neutralization (Thomas et al., 2003) . The 92UG046-T8 isolate was tested for neutralization by four different anti-envelope monoclonal antibodies that have exhibited potent anti-HIV activities in vitro as described in the Materials and methods. The effects of antibody neutralization were monitored in MT-2 cells after infection with the 92UG046, 92UG046-T8, or IIIB isolate. None of the four monoclonal anti-envelope antibodies had any effects on infection or syncytium induction by the 92UG046-T8 isolate even though the parental 92UG046 isolate as well as the IIIB isolate were efficiently neutralized by these anti-HIV antibodies. However, pooled plasma from HIV-1-infected patients was able to neutralize the 92UG046-T8 isolate (Table 2 ). These data show that in spite of being CD4-independent, the 92UG046-T8 isolate is resistant to neutralization by different anti-envelope antibodies. But the 92UG046-T8 isolate could be efficiently neutralized by serum from HIV-infected individuals. Further studies are necessary to know the exact reason for this unusual resistance of the 92UG046-T8 isolate to monoclonal anti-envelope antibodies.
Sequence analysis and envelope fusion
Changes in the viral envelope are likely to be responsible for the phenotypic differences and fusogenic potential between the 92UG046-T8 and its parental 92UG046 isolates. We have previously reported the sequence of the envelope of the 92UG046-T8 isolate that contained a premature stop codon in the TM domain (Zerhouni et al., 2004b) . Others have also reported sequences from portions of the env gene encoding the gp120 from the parental 92UG046 isolate (Cornelissen et al., 1996 (Cornelissen et al., , 1997 . To further examine and compare the env genes from the 92UG046 and 92UG046-T8 isolates, we sequenced and cloned the complete envelope of the 92UG046 isolate from infected CD4+ cells (Fig. 3A) . Between the env genes of the 93UG046-T8 and the 92UG046 isolates, only 4 aa differences (one each in V1/V2 and V5, and two in the TM domain) were noticeable. The most remarkable of these changes was a single point mutation (a G to A substitution) in the 92UG046-T8 isolate that resulted in a premature stop codon (TGA) in the place of a tryptophan residue (TGG) in the parental strain. This premature stop-codon in the 92UG046-T8 isolate caused a truncated cytoplasmic tail that was 67 aa shorter in length when compared to its parental strain (Fig. 3A) .
To test whether the truncated envelope of the 92UG046-T8 isolate was able to mediate the enhanced fusogenic activity associated with this strain, the 293 cells were transfected with a vector expressing the cloned 92UG046-T8 env and tested for the env-mediated cell fusion. Although absence of rev gene may affect expression of HIV env (Jounai et al., 2003) , the 293 cells transfected with the 92UG046-T8 env gene expressed low but detectable level of envelope (Fig. 3B) . The presence of the 92UG046-T8 env in the transfected 293 cells was also confirmed by PCR and sequencing (data not shown). During culture of the 92UG046-T8 env-expressing 293 cells alone, morphologic changes indicative of cell fusion were noticeable in 293 cells expressing the 92UG046-T8 env, but not in 293 cells expressing either the 92UG046 or HXB2 env or 293 cells transfected with plasmids containing no envelope (data not shown). Cellular fusion became more prominent when the 92UG046-T8 env-expressing 293 cells were cocultured with uninfected CD4+ (MT-2), CD4-negative (B-LCL) lymphoid cells (data not shown), or non-lymphoid U87 cells (CD4-/CXCR4-/CCR5-), as large number of cells sequestered forming huge multi-nucleated giant cells after over-night co-cultures (Fig. 3C ). Co-cultures of the uninfected U87 cells with the 293 cells that were either transfected with the control plasmids lacking any envelope (Fig. 3D ) or 293 cells expressing control 92UG046 or HXB2 env (data not shown) did not show any signs for cellular fusion. Together, these results demonstrate that the envelope of the 92UG046-T8 strain was able to mediate the enhanced fusogenic phenotype associated with this isolate.
Infection of human and non-human cells
Previous studies with different lentiviruses have suggested that truncation of the transmembrane protein may result in an expansion of the virus host cells range (Johnston et al., 1993; Kodama et al., 1989; Lerner and Elder, 2000; . We examined the infectivity of the 92UG04-T8 and its parental 92UG046 isolates on different CD4-positive and CD4-negative human as well as non-human (monkey and chimpanzee) cells. As summarized in Table 1 , the 92UG046-T8, but not its parental 92UG04 isolate or prototype X4-tropic IIIB isolate, was able to infect a wide range of CD4+ as well as CD4-negative cells from different origins. Distinctive syncytia appeared within 2 -6 days after infection of primary lymphocytes from two monkeys and chimpanzees. Infection of the monkey/chimpanzee lymphocytes by the 92UG046-T8 isolate and not by its parental 92UG046 isolate was also evident by positive PCR and RT production as well as by an increasing viral titer (I.U.) even though no p24 antigen could be detected in the infected culture supernatants.
The 92UG046-T8 isolate was also able to infect CD4-negative transformed cell lines of human (U87 and HeLa) and monkey (COS-7) origins that are generally resistant to HIV-1 infection. Low levels of RT activity were detected after infection of these non-lymphoid cells with the 92UG046-T8 isolate, likely because of reduced virus production (Table 1) . Prominent syncytia were noticeable in U87 (Fig. 4A ), HeLa and COS-7 (data not shown) cells after infection with the 92UG046-T8 isolate, but not with the parental 92UG046 (data not shown) or IIIB isolate (Fig.  4B ). U87 cells are negative for expression of CD4 as well as commonly used HIV-1 co-receptors including CXCR4 and CCR5. We have previously shown that infection by the 92UG046-T8 isolate is independent of CD4 (Zerhouni et al., 2004b) . Our results in this study indicate that infection by the 92UG046-T8 isolate is also likely to be independent of the common HIV co-receptors. Induction of syncytia by the 92UG046-T8 isolate in non-lymphoid human and monkey cell lines generally took longer (9 -20 days) compared to the CD4+ T cell lines like the MT-2 cells or primary lymphocytes (1-4 days). However, it was evident that the non-lymphoid cell lines like the COS-7 cells became productively infected with the 92UG046-T8 isolate (Fig. 4D) , but not the parental 92UG046 (Fig. 4C) or IIIB isolate (data not shown), as these cells produced remarkable syncytia when co-cultured with uninfected MT-2 cells even after two (or more) passages of the infected COS-7 cells. Such results are only possible with productive infection of the COS-7 cells. Interestingly, not all human cell types were susceptible to infection with the 92UG046-T8 isolate. For example, CEM, a commonly used human CD4+ T cell line, was found resistant to infection or syncytium induction with the 92UG046-T8 isolate even though the parental 92UG046 isolate was able to infect and form syncytia with these cells (Table 1 ). The reason for the apparent resistance of the CEM cells against the 92UG046-T8 isolate remains unclear. However, cell-specific resistance against HIV (Gabuzda et al., 1992; Iwatani et al., 2001; Murakami and Freed, 2000; Reed et al., 2002) and SIV (Johnston et al., 1993; Mulligan et al., 1992 ) mutants has been reported in the past. Taken together, these results establish that the 92UG046-T8 isolate can infect a wide range of human and non-human cells of both CD4-positive and CD4-negative phenotypes.
Discussion
In this study, we have characterized the broad cellular tropism and high fusogenicity for both CD4-positive and CD4-negative cells by a primary HIV-1 isolate, 92UG046-T8 that has a sharply truncated envelope cytoplasmic tail. Apart from infection of CD4-positive and CD4-negative cells from humans, the 92UG046-T8 isolate was also infectious and fusogenic for primary lymphocytes from monkey and chimpanzee as well as transformed CD4-negative cells (COS) of monkey origin indicating a broad tropism for this isolate. An env clone derived from the 92UG046-T8 isolate was able to mediate syncytium formation after transfection into CD4-negative 293 cells suggesting that the truncated envelope of this isolate was likely responsible for the enhanced fusogenic phenotype of this strain. Our data also show that the 92UG046-T8 strain is highly infectious and fusogenic even though it produces little viral antigens (p24 and RT), making this isolate difficult to detect by the commonly used assays for HIV detection.
Retroviruses of different origins including HIV have shown enhanced fusogenic activities, often in spite of reduced virus production, when their envelope cytoplasmic tails were truncated (Brody et al., 1992; Dubay et al., 1992a Dubay et al., , 1992b Earl et al., 1991; Gabuzda et al., 1992; Johnston et al., 1993; Jones et al., 2002; Kowalski et al., 1987; LaBranche et al., 1999; Lerner and Elder, 2000; Mulligan et al., 1992; Ritter et al., 1993; Zingler and Littman, 1993 ). An increase in the membrane fusion activity may be a mechanism that enhances entry of viruses into the target cells. Deletion of the cytoplasmic domain of the Mason -Pfizer monkey virus has made the mutant more fusogenic in spite of inefficient glycoprotein incorporation (Brody et al., 1992; Dubay et al., 1992b) . A marked increase in cell fusion was also associated with FIV (Lerner and Elder, 2000) and SIV (Johnston et al., 1993; Zingler and Littman, 1993 ) mutants with truncated envelope. A number of these short-tail lentiviruses emerged spontaneously during propagation of the wild-type isolates in unnatural host cells suggesting that selective pressure may play a role in the emergence of these novel variants (Hirsch et al., 1989; Kodama et al., 1989; Ritter et al., 1993) . There is precedent that HIV may also shed its long cytoplasmic tail and infect a broad range of unusual cell types. 8x, a IIIB mutant with a truncated envelope cytoplasmic tail (8x) that emerged spontaneously during the passage of the wild-type isolate on a CD4-negative T cell line, became CD4-independent and showed enhanced fusogenicity . The truncated cytoplasmic tail of the 8x mutant was solely responsible for the enhanced fusogenic activity and it played an essential role for infection of the CD4-negative cells (Edwards et al., 2002; LaBranche et al., 1999) . Similarly, the truncated cytoplasmic domain of an FIV mutant was found to be exclusively responsible for its enhanced fusogenic nature (Lerner and Elder, 2000) . The truncated envelope of the 92UG046-T8 isolate studied here was able to induce fusion with cells that are generally resistant to HIV entry including U87 cells that are negative for CD4, CCR5, or CXCR4 (Fig. 3C) . The enhanced fusogenic ability of the 92UG046-T8 isolate was likely related to its novel envelope structure. There were only 4 aa differences in the envelope of the 92UG046-T8 isolate compared to its parental strain that did not show CD4-independence or enhanced fusogenicity. The most remarkable of these sequence changes was the premature stop codon in the TM region of the 92UG046-T8 isolate that led to a sharply truncated cytoplasmic tail (Fig. 3A) . Although future mutagenesis and recombination studies would be necessary to identify the precise roles played by the aa changes in the Fig. 4. (A -B) Induction of syncytia in U87 cells after infection with the 92UG046-T8 isolate. U87 cells were infected either with 92UG046-T8 (A) or IIIB (B) isolates, passed at regular intervals, and monitored for induction of syncytia for up to 8 weeks. Both pictures of syncytia shown here in the 92UG046-T8-infected cells (A) were taken after 3 passages (18 days after infection). Simultaneous infections of the U87-CD4-CXCR4 cells were also followed that produced similar syncytia by both the 92UG046-T8 and IIIB isolates (data not shown). (C -D) Induction of syncytia by 92UG046-T8-infected COS-7 cells. COS-7 cells were infected either with the parental 92UG046 (C) or the 92UG046-T8 (D) isolate and passaged twice. After the second passage, the infected COS-7 cells were plated overnight and then overlaid with equal number of uninfected MT-2 cells. Syncytium formation was monitored daily. The syncytia (marked by arrows) with the 92UG046-T8-infected co-cultures were observed 48 h after the addition of the MT-2 cells.
92UG046-T8 envelope, based on the previous studies with FIV, SIV, and HIV viruses (Chakrabarti et al., 1989; Edwards et al., 2002; Hirsch et al., 1989; Kodama et al., 1989; LaBranche et al., 1999; Lerner and Elder, 2000) , the truncated tail of the 92UG046-T8 isolate is likely responsible for the highly fusogenic phenotype of this variant. Cytoplasmic tail-deleted animal immunodeficiency viruses found in vivo exhibited a broader cellular tropism suggesting a possible evolutionary role for these mutants (Chakrabarti et al., 1989; Hirsch et al., 1989; Kodama et al., 1989; Lerner and Elder, 2000) . The 92UG046-T8 isolate described here was present as a minority variant in the original viral quasispecies (Fig. 1) , which strongly suggests that the 92UG046-T8 mutant emerged in vivo, possibly indicating a niche in some patients for variants that can infect other cell types.
Supernatants from cells infected with the 92UG046-T8 isolate contained little viral RNA, a low level of RT activity, and almost undetectable viral p24 antigen, while the levels of infectious viral particles (I.U.) in these supernatants remained extremely high indicating highly infectious nature of this isolate (Table 1 , Fig. 2A ). It seems that the 92UG046-T8 isolate may be efficient in spreading infection by cell -cell viral transmission. Several studies have suggested that truncation of the viral envelope may severely affect infectivity because of defects in glycoprotein incorporation and/or essential Gag/Env interactions (Dubay et al., 1992b; Freed and Martin, 1996; Murakami and Freed, 2000; Piller et al., 2000) . Dubay et al. found that any truncation from the cytoplasmic tail of more than 19 amino acids almost completely abrogates infectivity of HIV-1 isolates (Dubay et al., 1992b) . Similarly, Gabuzda et al. have reported that RT activity in supernatants from cells infected with HIV-1 mutants with truncated cytoplasmic tail was reduced by more than 90% compared to the viruses with full-length cytoplasmic tails (Gabuzda et al., 1992) . Interestingly, the tail-deleted mutants in these studies also exhibited enhanced syncytium-inducing capacity in spite of little virus production. Another study has indicated that the increased formation of syncytia by a cytoplasmic taildeleted SIV mutant could be related to an over-expression of the envelope protein on the cell surface even in the absence of active virus replication (Johnston et al., 1993) . We did not observe any appreciable changes in the level of 92UG046-T8 envelope expression either on the infected cells or cells transfected with the viral envelope. Truncation of the TM domain of HIV-1, HIV-2, and SIV mutants have been shown to influence fusion and infection activities by altering the conformation of the external domain (SU) of the viral envelope (Edwards et al., 2002; Hoffman et al., 1999; Mulligan et al., 1992; . The cytoplasmic tail of the Moloney murine leukemia virus (MoMuLV) envelope protein has also been shown to influence the conformation of the extracellular domain (Aguilar et al., 2003) . We postulate that a significant reduction in the length of the cytoplasmic tail of the 92UG046-T8 isolate probably induced a conformational change in the receptorbinding SU domain making this isolate inherently more infectious and fusogenic in spite of reduced level of virus production.
Our previous study has identified two different CD4-independent isolates, 92UG046-T8 and 93US143-T8, that were able to induce syncytia in CD8+/CD4À lymphocytes (Zerhouni et al., 2004b) . Unlike the 92UG046-T8 isolate, the 93US143-T8 isolate was not able to infect or induce syncytia in U87 cells (Zerhouni et al., 2004b) . We have recently shown that infection of CD8+/CD4À T cells by the 93US143-T8 isolate is dependent on CXCR4 (Zerhouni et al., 2004a) . Entry of the 92UG046-T8 isolate into CD4-negative cells does not appear to be dependent on CXCR4 as it can readily infect U87 cells that do not express CXCR4 (Fig. 3C and data not shown) . The exact mode for viral entry into different cell types by the 92UG046-T8 isolate remains unknown at present. Inhibitors against known pathways for HIV-1 entry including antibodies and/or antagonists against the CD4, CXCR4, and CCR5 were also not able to block infection by the 92UG046-T8 isolate (unpublished observation). Several anti-envelope monoclonal antibodies including the highly potent b12 antibody (directed against the CD4-binding region) were also unable to neutralize the 92UG046-T8 isolate (Table 2) . Together, these results suggest that the 92UG046-T8 isolate may use a novel pathway(s) for infection of CD4-negative cells (unpublished observation). Studies are in progress to identify the exact mode of entry for the 92UG046-T8 isolate into the CD4-negative cells.
The prevalence of viruses with truncated cytoplasmic tail like the 92UG046-T8 isolate in HIV-1-infected patients at large remains unclear at the present time, as does the clinical significance of this highly unusual HIV-1 variant with broad tropism and enhanced fusogenicity. It is well recognized that selection forces may greatly affect the evolution of retroviruses (Overbaugh and Bangham, 2001) . A wide range of CD4-negative cells in vivo become susceptible to HIV-1 infection with the advancement of the disease indicating possible evolution of more robust HIV-1 mutants (Bhattacharya et al., 2003; Doms, 2001; Fauci, 1996) . The emergence of HIV mutants with truncated cytoplasmic tails and enhanced fusogenic potential in vivo would likely enhance infection of a wider variety of different cell types. Although HIV strains that can infect CD4-negative cells have been reported, these viruses are usually found to be more sensitive to antibody neutralization in vitro (Thomas et al., 2003) , which may not necessarily be relevant in vivo. Although the 92UG046-T8 isolate could be neutralized in vitro by pooled sera from asymptomatic HIV-infected individuals, the virus remained resistant to several monoclonal anti-envelope antibodies suggesting a more resistant nature for this isolate (Table 2) . But in spite of the robust nature of the 92UG046-T8 isolate, it is not clear why this mutant existed only as a minority variant in the viral quasispecies (Fig. 1) . The 92UG046-T8 strain was isolated from a Ugandan patient with subtype D infection, but apart from the AIDS status, very little information is available about this patient (Cornelissen et al., 1996 (Cornelissen et al., , 1997 . It is possible that the 92UG046-T8 isolate emerged soon before the clinical sample was collected from this patient. Nevertheless, there is little argument that the emergence of HIV-1 mutants like the 92UG046-T8 isolate in vivo would likely enhance infection of a wide range of different cell types. In view of our findings in this study coupled with the existing evidences from previous studies with cytoplasmic tail-deleted HIV and SIV mutants (Johnston et al., 1993; Jones et al., 2002; Kodama et al., 1989; Shimizu et al., 1990) , it will be important to search the viral quasispecies in other patients, especially in the later stages of HIV-1 disease for the existence of similar atypical HIV-1 mutants with truncated cytoplasmic tail and expanded cellular tropism.
Materials and methods
Viruses
The parental virus (92UG046) from which the cytoplasmic tail-deleted HIV-1 strain was isolated came from the viral quasispecies of a Ugandan AIDS patient that was originally collected in 1992 as part of the WHO Global Program on AIDS (obtained through the NIH AIDS Research and Reference Reagent Program (ARRRP); catalog no. 1773). The cytoplasmic tail-deleted 92UG046-T8 strain was isolated from the bulk viral quasispecies in short-term culture through a stringent selection method from infected CD8+ T cells that has been described recently (Zerhouni et al., 2004b) . Briefly, highly purified CD8+ lymphocytes from a healthy donor were infected with the bulk quasispecies (92UG046) and 3 days after infection, the purified CD8+ cells were further sorted by FACS to obtain highly purified CD8+ cell population that was free from CD4 mRNA. The 92UG046-T8 isolate was grown by shortterm (2 -3 weeks) co-cultures of the infected and sortpurified CD8+ cells with CD4-depleted PBMC from healthy donors. The parental 92UG046 isolate was simultaneously grown in PHA-stimulated CD4+ cells from normal donors by standard method and used as control. Laboratory X4-tropic IIIB, R5-tropic JR-FL, and several other known X4-or R5X4-tropic primary isolates (92UG001, CMU08, 93US151) were also used as additional controls in these experiments (Zerhouni et al., 2004b) .
Cells and Infections
For the infection studies, purified CD4+ (or PBMC) and CD8+ cells from healthy individuals were used. In addition, human CD4-positive (MT-2, CEM) and CD4-negative (U87, HeLa, 293) as well as CD4-negative (COS-7) monkey cell lines were also used for infection studies. In some experiments, primary lymph node cells from two healthy macaques and chimpanzees were used to test infectivity of different viral isolates. Unless specifically mentioned, all infections were performed with various HIV-1 isolates using a multiplicity of infection (M.O.I.) between 0.1 and 0.05. The culture conditions for isolation and infection of primary PBLs or purified CD4+ and CD8+ cells have been described in the past (Saha et al., 2001; Zerhouni et al., 2004b) . All primary cells were stimulated by PHA activation (1 Ag/ml) for 48 h prior to infection and then cultured in IL-2 containing RPMI 1640 medium (supplemented with 10% FCS). Infection and replication of different viral isolates were monitored by p24 ELISA as well as by reverse transcriptase (RT) assays. In addition, viral replication and the presence of biologically infectious viruses were also followed by calculating the infectious viral particles (I.U.) present in the culture supernatants at different time points by determining the 50% tissue culture infectious dose (TCID 50 ) with MT-2 cells through an end-point dilution using the Reed-Muench accumulative method (Zerhouni et al., 2004b) . In some experiments with the non-permissive CD4-negative cell lines (e.g., U87, HeLa, COS-7), infections were monitored by PCR and by co-culture (at 1:1 ratio) of the infected cells with other indicator cell lines at various times after infection as indicated. These co-culture experiments were often carried out after several passages of the infected cells to rule out the possibility of any residual viruses that may be present in the culture supernatants without productive infection.
Syncytium induction and cytopathicity
Since short-tail viruses are known to induce enhanced fusion (Dubay et al., 1992b; LaBranche et al., 1999) , induction of syncytia and cytopathic effects on infection were closely followed in these experiments. Cell fusion induced by different viral isolates was monitored microscopically by following the development of syncytia in the infected cells. Infected adherent cell lines that were mostly of CD4-negative phenotype (e.g., U87, 293, COS-7) were passed regularly with trypsin/EDTA digestion and formation of syncytia in these cells was followed for up to 8 weeks. Viruses produced by the infected cells in the culture supernatants were further characterized for syncytiuminducing (SI) phenotype by their ability to form syncytia with MT-2 cells. The cytopathicity of different isolates was followed by close monitoring of the number of viable cells by trypan blue as well as PI staining (Zerhouni et al., 2004b) .
Antibodies and neutralization
Several known anti-HIV antibodies were used to test their effects on infection by the 92UG046-T8 isolate. The monoclonal antibodies used were Mab 447-52D, which recognizes the GPXR motif at the tip of the V3 loop of the envelope (Nyambi et al., 1998) ; Mab b12, which is directed against the CD4 binding region of the envelope (Burton et al., 1991) ; Mab 268-D, which reacts with the V3 epitope HIGPGR (Gorny et al., 1991) ; and Mab ID6, which is directed against the first 204 aa of gp120 of a recombinant LAV-1 isolate (Dickey et al., 2000) . These anti-envelope antibodies are known to efficiently neutralize different laboratory as well as clinical HIV-1 isolates. In addition, human immunodeficiency virus immune globulin (HIVIG), pooled plasma of several asymptomatic HIV-1-positive donors that has broad HIV neutralizing activity, was also used to test neutralization. These antibodies were obtained through the ARRRP. In view of the unique nature of the 92UG046-T8 isolate that produced striking syncytia but little p24 antigen after infection, modified neutralization assay was performed. Briefly, each viral isolate (92UG046-T8, 92UG046, or IIIB) were mixed with limiting dilution of different anti-HIV antibodies (highest concentration of 20 -40 Ag/ml). Control samples were treated with isotype control antibody for each monoclonal antibody used. After incubation for 1 h at 37 -C, MT-2 cells were infected with the virus-antibody mixture in triplicates. The number of syncytia per hpf was counted and supernatants were collected for viral assay (TCID 50 ) at regular intervals. Neutralization was measured by comparing the number of syncytia present and the level of viral titers. At least 50% reduction in the total number of syncytia and >90% reduction in the viral titers were considered positive for neutralization by each antibody.
Heteroduplex tracking assay (HTA) and cloning
The relative abundance of the gp41 stop codon sequence variant present in the parental 92UG046 viral quasispecies was determined through a novel approach by using a specific HTA that included the premature termination site of the 92UG046-T8 isolate. Briefly, viral RNA was isolated using a QIAamp Viral RNA kit (Qiagen) from 140 Al supernatant of the original 92UG046 isolate or the pellet from 10 ml supernatant of the 92UG046-T8 isolate. A 148-bp region of gp41 was amplified from the RNA by RT-PCR using primers 1773for (5V-TTCAGCTACCACCGCTTGA-GAGAC-3V, HXB numbering 8519-8542) and 1773rev (5V-GCAAGCTAACAGCACTATTCTTTAGTTCC-3V, HXB numbering 8666-8638). For the original 92UG046 RNA, reverse transcription (RT) reactions consisted of 5 Al of the eluted viral RNA, 1Â AMV RT buffer (Roche), 1 mM each of dNTP (Clontech), 15 pmol 1773rev primer, 10 U Rnase inhibitor (Fisher Scientific), and 12.5 U AMV RT (Roche) in a total volume of 10 Al. The RT reaction mixture remained basically the same for the 92UG046-T8 RNA except that 1Â Expand High Fidelity buffer with MgCl2 was used and 0.67 mM each of dNTP and 20U Rnase inhibitor were used for each reaction. Reactions were incubated at 42 -C for 30 min and then at 95 -C for 5 min to inactivate the AMV RT. All PCR reactions were carried out as previously described (Zerhouni et al., 2004b) . The same region was amplified from two env clones derived from 92UG046 and 92UG046-T8 RNA that did not and did have the stop codon, respectively. A corresponding probe was constructed by amplifying the same region from a YU-2 env subclone (Li et al., 1992) and ligating the product into the pT7Blue-3 vector (Novagen). The downstream EcoRI site was destroyed by Klenow fill-in. Mutagenesis was performed using the Quick Change mutagenesis system (Stratagene) to change the GGTGGGGAGT sequence to GGTGGtGAGT, which placed a new mutation adjacent to the site of the stop codon to form a cluster of mismatches in the heteroduplex when the stop codon was present to change the heteroduplex mobility. To label the probe on one strand only, the probe sequence was cleaved on the upstream side with EcoRI, end-labeled with 35 S by Klenow fill-in, and removed from the vector by digestion with HindIII. The labeled probe and the products were mixed, heated at 95 -C for 2 min, and allowed to cool at room temperature for 5 min before separation of the heteroduplexes on a 12% nondenaturing polyacrylamide gel and the heteroduplexes containing a labeled probe strand were visualized by autoradiography and phosphorimaging. The relative abundance of each band within a lane was determined using Fragment Analysis software (Molecular Dynamics). The RT-PCR product from the original 92UG046 isolate was cloned into the pT7Blue-3 vector and clones were screened by HTA. Clones of interest were sequenced to verify their sequence against the 92UG046 env clone.
Viral envelope and fusion
The envelope of the 92UG046-T8 isolate was sequenced and cloned previously (Zerhouni et al., 2004b) . The whole envelope of the parental 92UG046 isolate was also sequenced and cloned for comparison following similar procedures (Saha et al., 2001; Zerhouni et al., 2004b) . The fusogenic potential of the 92UG046-T8 env clone was examined by a fusion assay (Dubay et al., 1992b) . Briefly, a low-copy-number plasmid expression vector, pWKS-BC, was constructed in which the expression cassette containing the CMV promotor and SV40 poly(A) was removed from the pBK-CMV (Stratagene) with AflIII, the ends were filled-in with Klenow and ligated into the PvuII-digested low-copy-number plasmid pWKS30 (Wang and Kushner, 1991) . The 92UG046-T8 env gene was cloned into the EcoRI site in pWKS-BC to create pWBC-Env 92UG046-T8 . The orientation of the envelope was affirmed by sequencing. Fresh 293 cells were seeded on a 60-mm tissue culture dish to 60 -70% confluence and co-transfected by a modified calcium phosphate method (Jordan et al., 1996) with 6 Ag of the pWBC-Env 92UG046-T8 and 2 Ag of pBK-CMV which carries a neo r gene for G418 resistance. After overnight incubation, the transfected cells were maintained in selection medium.
The transfected 293 cells were examined for the expression of the viral envelope through indirect FACS analysis by staining first with pooled sera of asymptomatic HIV-infected patients (obtained from the ARRRP; catalog no. 3957) or normal human serum (as control), followed by incubation with fluorescein isothiocyanate (FITC)-conjugated F(abV) 2 goat anti-human IgG (Sigma) antibody. 293 cells transfected with the control plasmids but without any envelope and 283 cells expressing the envelope of the HXB2 isolate (obtained through the ARRRP) were used as controls for these experiments. The envelope-expressing 293 cells were examined microscopically for any morphologic changes for fusion. Envelope-mediated cell fusion was further visualized by co-culture experiments. For this purpose, a sub-confluent layer of the 293 cells expressing the envelope of the 92UG046-T8 isolate (or control 293 cells) was cultured overnight and then overlaid with equal number of uninfected cells. Cell fusion was examined microscopically and also after staining with the MayGrunwald/Giemsa stain (Dubay et al., 1992b) .
Nucleotide accession numbers
The complete gp160 sequences of the 92UG046-T8 and 92UG046 isolates have been submitted to the GenBank (accession numbers AY623599-AY623600).
